The present invention relates generally to a method and instrument for detecting an ocular disorder and, more particularly, to an instrument and a composition for detecting biofilms on the eyelid margin and methods of using said instrument and composition.
Ocular disorders such as those relating to eyelid margin disease are particularly common pathological conditions of the ocular adenexa. By way of example, these disorders include blepharitis, meibomitis, and dry eye syndrome. Eyelid margin disease usually includes a buildup of debris on the eyelid margin of the eye of an individual. The debris may include bacteria, scurf, mucus, oils, and other secreted fluids. Despite advances in ophthalmology and medical treatments in general, the recommended treatments for these exemplary common ocular disorders has remained essentially unchanged for decades.
Eyelid margin disease may be the most common eye disease in the world and, unfortunately, also one of the most poorly understood and under-treated eye diseases of our time. There is no single diagnostic test for eyelid margin disease, and therefore the exact prevalence of this disease is difficult to determine. Most prevalence studies have failed to recognize blepharitis and dry eye disease as differing stages of the same disease process, and thus there is a significant amount of overlap when evaluating the prevalence of eyelid margin disease. Based on the self-reporting of dry eyes in the Beaver Dam Offspring cohort, the prevalence of dry eye was 14.5 percent (18.9 percent in women and 10.5 percent in men). Other studies have estimated dry eye prevalence at 5 to 32 percent of the population age 50 years and over. Self-reporting is a poor protocol for estimating dry eye disease because early meibomian gland disease is often asymptomatic. Studies on blepharitis prevalence have focused on doctor reporting, thereby evaluating their existing patient populations to determine prevalence. This method is obviously skewed towards patients already under the care of an eye doctor, so is pre-selected towards patients with existing symptoms. These numbers range from 40 percent to 65 percent. The complexity of over-lapping symptoms makes determination difficult as well. When factoring the number of contact lens wearers in the United States, currently around 40 million, it is easy to see that eyelid margin disease is a significant eye problem worldwide, with a need for better understanding and treatment of this chronic disease.
It is well accepted that dry eye and blepharitis are inflammatory-based diseases. Indeed, a prominent eye drop medication, Restasis®, is based on suppressing existing inflammation. A better approach would be to identify a source of inflammation that can account for the many presentations of DEBS. In doing so, the nature of this disease may be better understood and better treatment options may be formulated to address the source of inflammation. There exists a need for a medication that addresses the source of inflammation thereby preventing inflammation from occurring in the first place.
Historically, blepharitis has been treated by advising patients to perform home lid hygiene regimes, which are ineffective and difficult for most patients to do. There is a multitude of home lid hygiene products such as surfactant-based lid wipes, hypochlorous acid, and warm compresses. Dry eye disease treatments have been mostly ameliorative, with a multitude of various artificial tears on the market, and more recently, in-office treatments such as Lipiflow®, Meiboflow®, manual meibomian gland expression, and BlephEx®, which is an in-office treatment that allows doctors to completely remove lid margin biofilms. None of these treatments address a recurrence of the source of inflammation and must be repeated at regular intervals.
There is a need for a method and apparatus for use in diagnosing ocular disorders, such eyelid margin diseases, that addresses present challenges and characteristics such as those discussed above.
In accordance with an exemplary embodiment of the invention, an instrument and a composition for detecting biofilms on the eyelid margin and methods of using said instrument and composition is described. The present invention provides improved compositions, devices, and methods for detecting biofilm on an eyelid margin of an eye. An aspect of the invention is directed to a composition for detecting biofilm on an eyelid margin. The composition includes a dye that binds to the biofilm and a solution that is biocompatible with the eye.
Another aspect of the invention is directed to a method for detecting biofilm on an eyelid margin of an eye. The method includes applying a solution to the eye or the eyelid margin so that a dye in the solution binds to the biofilm.
Another aspect of the invention is directed to a handheld camera for detecting biofilm on an eyelid margin of an eye. The handheld camera includes a housing, an image sensor, and a lens including a focal length determined by a distance between the lens and the eyelid margin.
Another aspect of the invention is directed to a method for detecting biofilm on an eyelid margin. The method includes capturing an image of the eyelid margin using a handheld camera and determining if the biofilm is present on the eyelid margin.
Another aspect of the invention is directed to a system for detecting biofilm on an eyelid margin of an eye. The system includes a composition and a handheld camera. The composition comprises a dye that binds to the biofilm, and a solution that is biocompatible with the eye. The handheld camera comprises a housing, an image sensor, and a lens including a focal length determined by a distance between the lens and the eyelid margin.
The steps and elements described herein can be reconfigured and combined in different combinations to achieve the desired effects in an instrument and a composition for detecting biofilms on the eyelid margin and methods of using said instrument and composition, as may be needed in the art. These and other objects and advantages of the present invention shall be made apparent from the accompanying drawings and the description thereof.
Various additional features and advantages of the invention will become more apparent to those of ordinary skill in the art upon review of the following detailed description of one or more illustrative embodiments taken in conjunction with the accompanying drawings. The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and, together with a general description of the invention given above, and the detailed description given below serve to explain the one or more embodiments of the invention.
The Detailed Description refers to accompanying drawings to illustrate exemplary embodiments consistent with the present disclosure. References in the Detailed Description to “one exemplary embodiment,” “an exemplary embodiment,” an “example exemplary embodiment,” etc., indicate that the exemplary embodiment described may include a particular feature, structure, or characteristic, but every exemplary embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same exemplary embodiment. Further, when a particular feature, structure, or characteristic is described in connection with an exemplary embodiment, and it is within the knowledge of those skilled in the art(s) to affect such feature, structure, or characteristic in connection with other exemplary embodiments whether or not explicitly described, such other embodiments, so affected, are intended to be suggested and included in this description.
The exemplary embodiments described herein are provided for illustrative purposes, and are not limiting. Other exemplary embodiments are possible, and modifications may be made to the exemplary embodiments within the spirit and scope of the present disclosure. Therefore, the Detailed Description is not meant to limit the present disclosure. Rather, the scope of the present disclosure is defined only in accordance with the following claims and their equivalents.
The Detailed Description of the exemplary embodiments will so fully reveal the general nature of the present disclosure that others can, by applying knowledge of those skilled in the relevant art(s), readily modify and/or adapt for various applications such exemplary embodiments, without undue experimentation, without departing from the spirit and scope of the present disclosure. Therefore, such adaptations and modifications are intended to be within the meaning and plurality of equivalents of the exemplary embodiments based upon the teaching and guidance presented herein. It is to be understood that the phraseology or terminology herein is for the purpose of description and not of limitation, such that the terminology or phraseology of the present specification is to be interpreted by those skilled in relevant art(s) in light of the teachings herein.
An aspect of the invention is directed to a method of detecting biofilms on the eyelid margin by using a dye that specifically binds to biofilms. A composition for detecting biofilms may be in the form of drops that are suitable for use in and around the eye. Compositions for detecting biofilms may include dyes that are similar to dyes used in mouth rinses that show plaque on teeth. Suitable dyes include phloxine B, D & C Red 28, and FD & C Blue. One of ordinary skill in the art will appreciate that exact components of the composition may vary based on the intended use.
In use, the composition stains, or otherwise increases the visibility of, any biofilm on the subject's eyelids. The dye may be administered in formulations that include additional excipients and solvents as are known in the art for use in compounds being applied to the eye or eyelid margin. For example, the dye compositions may include one or more of the following: balanced salt solutions, water, gelling solutions, and stabilizers. In an embodiment, the dye is in an isotonic solution to reduce any irritation of the eye by the application of the composition.
In embodiments of the invention, dye compositions are administered to the eye lid margin to detect biofilms on the eyelid margin. The dye composition may be administered topically. In an embodiment, the dye composition is administered as an eye drop. Additionally or alternatively, the dye composition may be applied directly to the eyelid margin for more specific application. In an embodiment, the dye composition is administered as a gel or cream directly to the eyelid margin, such as with a fingertip or swab.
Compositions for detecting biofilms according to embodiments of the invention have a variety of applications. In one application, a doctor may use a composition to help with the education process of the patient. Another exemplary use includes a doctor using a composition to determine the efficacy of a biofilm removal procedure such as a BlephEx® microblepharoexfoliation treatment. Additionally, a patient can use a composition at home to determine if a biofilm is present and whether a removal treatment should be scheduled.
An aspect of the invention is directed to a device for detecting biofilms on the eyelid margin. With reference to
Still referring to
With reference to
With reference to
Referring again to
The focal length of the camera 10 is determined by the distance between the lens 44 and the eyelid margin. The focal length may be greater than that of conventional handheld microscopes. For example, the focal length of the lens 44 may be between about 0-30 mm. The axially aligned focusing thumbwheel 56 improves the ability of a user to adjust the focus with the same hand holding the camera 10 against the subject's eye and helps to minimize movements of the camera 10, which are magnified in effect due to the nature of the camera 10. In that regard, axial movement of the thumbwheel 56 results in an adjustment of the focus of the image. Thus, only one finger is needed to focus the image. When the camera 10 is held by a user, finger movement in the axial direction is a natural extension and flexion of finger, in line with the hand and the rest of the fingers of a user. Moreover, force applied in the axial direction against the camera 10 does not affect the stability of the camera 10 because the camera 10 is resting against the patient in the axial direction. Thus, any force applied in the axial direction in adjusting the camera 10 is balanced by the camera 10 resting against the patient. In contrast, traditional focusing components are cylindrical and extend circumferentially around a handheld camera housing. Circumferential movement of the focusing component, such as twisting a focusing ring, around the handheld camera is required to adjust the focus. Such a traditional focusing component would significantly impact the ease of using the camera 10 with one hand. Further, circumferential movement of the focusing component would require force to be applied in the direction perpendicular to axis of the camera 10. An applied perpendicular force will destabilize the camera 10 since the applied perpendicular force would be acting against the force holding the camera 10 against the patient. These two competing forces result in small movements that, because of the magnification of the camera 10, create blur and impede the focusing of the camera 10.
Still referring to
With further reference to
With reference to
In an aspect of the present invention, Wi-Fi functionality may be incorporated into the camera 10 so that high magnification, high resolution images may be sent to an electronic device (not shown). For example, in an embodiment the electronic device may be a smartphone, tablet, or computer. In use, the Wi-Fi functionality may be used to send an image of a patient's eyelids to the patient's smartphone or other electronic device for his or her viewing during or after examination. In an embodiment, the camera 10 includes a Wi-Fi module board 106 as shown in
During use, the user rotates the dial 104 to turn on the camera 10. Next, the camera 10 is placed such that the cup 14 contacts the face of the patient, encircling the eye. The user may adjust the light intensity using the dial 104 and the zoom of the image using the digital zoom button 54. To focus the image, the user may rotate the thumbwheel 56 causing the lens carriage 58 and, thus, the lens 44 to move towards or away from the patient's eye. When the user is satisfied with the light intensity, zoom, and focus of the image, the image may be captured by pressing the capture button 52. As described above, the image may be wirelessly transferred to an electronic device (not shown) for display and evaluation.
An aspect of the invention is directed to kit for detecting biofilms on the eyelid margin. The biofilm detection dye and a device for detecting biofilms on the eyelid margin (e.g., the camera 10) may be used in concert with one another or separately.
While the present invention has been illustrated by the description of one or more embodiments thereof, and while the embodiments have been described in considerable detail, they are not intended to restrict or in any way limit the scope of the appended claims to such detail. Additional advantages and modifications will readily appear to those skilled in the art. The invention in its broader aspects is therefore not limited to the specific details, representative apparatus and method and illustrative examples shown and described. Accordingly, departures may be from such details without departing from the scope of the general inventive concept.
This application is a continuation-in-part of U.S. patent application Ser. No. 15/584,527, filed on May 2, 2017, which claims priority to U.S. Provisional Patent Application No. 62/330,657, filed May 2, 2016, each of which is hereby expressly incorporated by reference into this application in its entirety.
Number | Date | Country | |
---|---|---|---|
62330657 | May 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15584527 | May 2017 | US |
Child | 16868620 | US |